A Multigene Prognostic Assay for Selection of Adjuvant Chemotherapy in Patients with T3, Stage II Colon Cancer: Impact on Quality-Adjusted Life Expectancy and Costs-Reference-Cited by-同舟云学术

A Multigene Prognostic Assay for Selection of Adjuvant Chemotherapy in Patients with T3, Stage II Colon Cancer: Impact on Quality-Adjusted Life Expectancy and Costs

Published:2012-12 Issue:8 Volume:15 Page:1014-1021
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Hornberger John,Lyman Gary H.,Chien Rebecca,Meropol Neal J.

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference44 articles.

1. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

2. National Cancer Institute: Division of Cancer Control & Population Sciences: Surveillance Research Program: Cancer Statistics Branch. Surveillance Epidemiology and End Results (SEER) Program. SEER*Stat Database. http://seer.cancer.gov/. [Accessed 2010].

3. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer;Benson;J Clin Oncol,2004

4. Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer;Schrag;J Clin Oncol,2002

5. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: Colon cancer V.3.2010. www.nccn.org. [Accessed November 21, 2011].

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is Risk-Stratifying Patients with Colorectal Cancer Using a Deep Learning-Based Prognostic Biomarker Cost-Effective?;PharmacoEconomics;2024-04-07

2. Health economic evidence for adjuvant chemotherapy in stage II and III colon cancer: a systematic review;Cost Effectiveness and Resource Allocation;2023-01-31

3. Cost-effectiveness of precision molecular diagnostic tests for stage II colorectal cancer;Annals of Translational Medicine;2022-12

4. Evaluating the quality of the economic evidence in colorectal cancer genomics studies;Personalized Medicine;2022-07

5. Oncotype DX testing does not affect clinical practice in stage IIa colon cancer;Medical Oncology;2022-02-12